BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2022 2:25:32 AM | Browse: 369 | Download: 659
 |
Received |
|
2021-03-08 12:47 |
|
Peer-Review Started |
|
2021-03-08 12:52 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-03 11:29 |
|
Revised |
|
2021-05-23 02:30 |
|
Second Decision |
|
2021-11-08 03:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-11-15 07:26 |
|
Articles in Press |
|
2021-11-15 07:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-10-30 21:36 |
|
Typeset the Manuscript |
|
2021-12-31 03:28 |
|
Publish the Manuscript Online |
|
2022-01-18 02:25 |
| ISSN |
2150-5330 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Review |
| Article Title |
Current treatment strategies and future perspectives for gastrointestinal stromal tumors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sugiyama Yoichi, Masaru Sassaki, Mohei Kouyama, Tatsuya Tazaki, Shinya Takahashi and Atsushi Nakamitsu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sugiyama Yoichi, MD, PhD, Doctor, Surgeon, Surgical Oncologist, Department of Gastrointestinal Surgery, JA Hiroshima General Hospital, Jigozen 1-3-3, Hatsukaichi 738-8503, Hiroshima, Japan. sugiyama0113@gmail.com |
| Key Words |
Gastrointestinal stromal tumor; Minimally invasive surgery; Laparoscopic surgery; Imatinib; Neoadjuvant therapy; Risk assessment |
| Core Tip |
Radical resection is the most effective treatment for gastrointestinal stromal tumors, but there are other options including minimally invasive surgery and multidisciplinary treatment, which involves the use of neoadjuvant therapy in consideration of tumor size and location. Combination with tyrosine kinase inhibitors is important for maximizing the therapeutic effect of surgery. To predict the effect, it is important to examine the presence of tumor mutations, including type, location of the mutation, and molecular subtype. We herein discuss the current treatment strategies for gastrointestinal stromal tumors and promising treatments based on clinical trials. |
| Publish Date |
2022-01-18 02:25 |
| Citation |
Sugiyama Y, Sasaki M, Kouyama M, Tazaki T, Takahashi S, Nakamitsu A. Current treatment strategies and future perspectives for gastrointestinal stromal tumors. World J Gastrointest Pathophysiol 2022; 13(1): 15-33 |
| URL |
https://www.wjgnet.com/2150-5330/full/v13/i1/15.htm |
| DOI |
https://dx.doi.org/10.4291/wjgp.v13.i1.15 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
